VOSOL HC
LOE Approachinghydrocortisone and acetic acid otic
NDAOTICSOLUTION/DROPS
Approved
Jun 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
VOSOL HC (hydrocortisone and acetic acid otic) is corticosteroid hormone receptor agonists [moa]. First approved in 1961.
Drug data last refreshed 16h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VOSOL HC is a topical otic solution combining hydrocortisone (a corticosteroid) and acetic acid for treatment of ear canal inflammation and infection. It works by activating corticosteroid hormone receptors to reduce inflammation while acetic acid provides antimicrobial support. This is a classic combination therapy indicated for otitis externa and related otic conditions.
LOE Approaching
As a 60+ year old product approaching loss of exclusivity, VOSOL HC team likely operates as a mature maintenance franchise with smaller commercial infrastructure focused on defending market share.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VOSOL HC offers limited career growth potential given its LOE-approaching status and minimal linked job activity. This role would suit professionals seeking stability in a mature franchise or those transitioning toward lifecycle management and generic defense strategies.
Brand ManagerProduct Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.